Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Commercial Financing Research & Development

Personal Genome Diagnostics And Cleveland Diagnostics Will Use New Funding To Expand Cancer Portfolios

  • News

Executive Summary

Personal Genome Diagnostics will use its funding to expand its liquid biopsy portfolio. Cleveland Diagnostics plans to develop early detection tests for lung and breast cancer.

You may also be interested in...



Minute Insight: Quidel And Labcorp Finish Big Year For IVD Deals With Major Acquisitions

Quidel will pay $6bn for Ortho Clinical Diagnostics. Labcorp will acquire Personal Genome Diagnostics for $575m.

Newer Therapy Areas Will Drive Women’s Health Funding In 2024

Women’s health startups focusing on areas of high unmet need such as menopause, infertility, preventive care and post-partum care will continue to attract investors in 2024. Meanwhile, machine learning and AI, as well as next-generation treatments such as psychedelic therapy, stand to drive advancements in the space.

News We’re Watching: Boston Scientific Closes Relievant, Medtronic's PFA Earns CE Mark, And More

Medtech Insight's News We're Watching highlights medtech industry news developments you may have missed over the last few weeks.

Table

View full table

Topics

Related Companies

Tags:
Commercial Financing Research & Development
Latest Headlines

EU member States Call For Action Over High-Risk IVDs and Eudamed Medical Device Database

No, I am Spartacus – Embecta Joins The Quell Against GLP-1 Hype

Medtech Industry Weighs In On EMA’s AI Regulation Proposals

Medtech Advocate Announces Retirement From House Of Representatives

See All
UsernamePublicRestriction

Register

MT143476

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By